Share Prices & Company Research

Stockbroking

e-Therapeutics

Current Price 3.99p Bid 3.90p Ask 4.10p Change 0.00%
Last Updated: 21/09/2019 21:04. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

e-Therapeutics plc is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. Its novel methodology and its Discovery Engine allow it to discover new and better drugs in a more efficient and effective way.

Financial Highlights Year Ended 31/01/2019

Turnover
£0.04m
Operating Profit
£-5.11m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-2.69

Key Personnel

Dr Raymond John Barlow
Chief Executive Officer
Iain Gladstone Ross
Executive Chairman
Steven Medlicott
Finance Director
Christine Helen Soden
Non-Executive Director
Prof Trevor Mervyn Jones
Non-Executive Director

Stock Details

EPIC
ETX
ISIN
GB00B2823H99
Shares in Issue
268,948,094
Market cap
£10.76m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
4.00p
Bid Price
3.90p
Ask Price
4.10p
Volume
425474
Change Today
0.00p
% Change Today
0.00%
Open
3.90p
Previous Close
4.00p
Intraday High
4.00p
Intraday Low
3.90p
52 Week High
7.50p
52 Week Low
1.43p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

e-Therapeutics Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Tangible Assets
0.0
0.1
Intangible Assets & Goodwill
0.1
0.1
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
0.2
0.2
Inventory
0.0
0.0
Trade & Receivables
0.4
0.6
Cash & Receivables
5.9
7.1
Other Current Assets & Assets Held for Resale
1.1
3.9
Total Assets
7.5
11.8

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Short Term Liabilities
0.7
1.0
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
0.7
1.0

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Net Assets
6.8
10.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Share Capital
0.3
0.3
Minority Interests
0.0
0.0
Retained Earnings
-58.6
-54.7
Share Premium Account
65.2
65.2
Other Equity
0.0
0.0
Total Equity
6.8
10.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Cashflow from Operating Activities
-3.7
-4.4
Cashflow Before Financing
-1.2
2.6
Increase / Decrease in Cash
-1.2
2.6

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jan 2019
31 Jan 2018
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-5.1
-6.8
Pre-Tax Profit
-5.1
-6.7
Profit / Loss for the Year
-4.0
-5.4
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.